PROTALIX BIOTHERAPEUTICS INC

CUSIP: 74365AAB7 Class: CONV BONDS

DAFNA Capital Management LLC's Holding History (CIK: 0001389933)

Note: Option positions (PUT/CALL) are excluded.

Q2 2018
Shares 2,500,000 Value ($000) $2,375 Avg Close — Range —
Q1 2018
Shares 2,500,000 Value ($000) $2,125 Avg Close — Range —
Q4 2017
Shares 2,500,000 Value ($000) $2,125 Avg Close — Range —
Q3 2017
Shares 2,500,000 Value ($000) $2,125 Avg Close — Range —
Q2 2017
Shares 2,500,000 Value ($000) $1,936 Avg Close — Range —
Q1 2017
Shares 2,500,000 Value ($000) $1,963 Avg Close — Range —
Q4 2016
Shares 2,500,000 Value ($000) $1,546 Avg Close — Range —
Q3 2016
Shares 2,500,000 Value ($000) $1,525 Avg Close — Range —
Q2 2016
Shares 2,500,000 Value ($000) $1,644 Avg Close — Range —
Q1 2016
Shares 2,500,000 Value ($000) $1,644 Avg Close — Range —
Q4 2015
Shares 2,500,000 Value ($000) $1,775 Avg Close — Range —
Q3 2015
Shares 4,000,000 Value ($000) $2,698 Avg Close — Range —
Q2 2015
Shares 4,000,000 Value ($000) $3,196 Avg Close — Range —
Q1 2015
Shares 4,000,000 Value ($000) $3,060 Avg Close — Range —
Q4 2014
Shares 4,000,000 Value ($000) $3,200 Avg Close — Range —